Outcome Domains, Outcome Measures, and Characteristics of Randomized Controlled Trials Testing Nonsurgical Interventions for Osteoarthritis.
Clinical Trials, Phase III as Topic
Cross-Sectional Studies
Follow-Up Studies
Hand Joints
/ pathology
Humans
Osteoarthritis, Hip
/ therapy
Osteoarthritis, Knee
/ therapy
Outcome Assessment, Health Care
Pain
Randomized Controlled Trials as Topic
Retrospective Studies
Rheumatology
/ methods
Treatment Outcome
Visual Analog Scale
OSTEOARTHRITIS
OUTCOME
RANDOMIZED CONTROLLED TRIAL
TREATMENT
Journal
The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
accepted:
13
02
2019
pubmed:
17
3
2019
medline:
21
5
2021
entrez:
17
3
2019
Statut:
ppublish
Résumé
Core outcome set (COS) is the minimum set of outcome domains that should be measured and reported in clinical trials. We analyzed outcome domains, prevalence of use of COS published by Outcome Measures in Rheumatology (OMERACT) initiative, outcome measures for outcome domains recommended by OMERACT COS, duration and size of randomized controlled trials (RCT) testing nonsurgical interventions for osteoarthritis (OA). We searched PubMed and analyzed RCT about nonsurgical interventions for OA published from June 2012 to June 2017. We extracted data about trial type, use of OMERACT COS, efficacy outcome domains, safety outcome domains, outcome measures used for COS assessment, duration, and sample size. Among 334 analyzed trials, complete OMERACT-recommended COS was used by 14% of trials. Higher median prevalence of using OMERACT COS was found in trials explicitly described as phase III, and trials of pharmacological interventions with followup ≥ 1 year, but both with wide range of COS usage. Trialists used numerous different outcome measures for analyzing core outcome domains: 50 different outcome measures for pain, 74 for physical function, 9 for patient's global assessment, and 5 for imaging. Suboptimal use of recommended COS and heterogeneity of outcome measures is reducing quality and comparability of OA trials and hinders conclusions about efficacy and comparative efficacy of nonsurgical interventions. Interventions for improving study design of trials in this field would be beneficial.
Identifiants
pubmed: 30877204
pii: jrheum.180985
doi: 10.3899/jrheum.180985
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM